Development of a panel of highly sensitive, equivalent assays for detection of antibody responses to velaglucerase alfa or imiglucerase enzyme replacement therapy in patients with Gaucher disease

Authors:

Abstract
No abstract available
Funding Information
  • Shire Human Genetic Therapies, Inc.

This publication has 15 references indexed in Scilit: